Leadership

Rihe Liu Ph.D.
Rihe Liu (Ph.D.) received his Ph.D. in biochemistry from the University of California at San Diego in 1996. Later he carried out postdoctoral work with Professor Jack W. Szostak at Massachusetts General Hospital and Harvard Medical School, trained in in vitro selection of functional biomolecules. During his postdoc research, he co-invented the mRNA-display technology that has been used by Bristol-Myers Squibb for the systematic development anti-cancer biopharmaceuticals.? Professor Liu joined the faculty at the University of North Carolina at Chapel Hill in 2001. He pioneered the application of mRNA-display technology for in vitro selection of proteins with desired functions from various natural proteome libraries and synthetic protein domain/polypeptide libraries. This technology laid the groundwork for the selection of novel targeting ligand and ‘TRAP’ protein as an antagonist for therapeutic targets.